Last reviewed · How we verify
NCT06816524
The Effects of Iron Treatment on Malaria and Measles Vaccine Response in Kenyan Infants With Iron Deficiency
NA trial testing Iron syrup in Iron Deficiencies in 324 participants. Not yet recruiting.
31 December 2027
Quick facts
| Lead sponsor | Nicole Stoffel |
|---|---|
| Phase | NA |
| Status | Not yet recruiting |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | quadruple |
| Primary purpose | other |
| Enrollment | 324 |
| Start date | 5 January 2026 |
| Primary completion | 31 December 2027 |
| Estimated completion | 30 April 2028 |
Drugs / interventions tested
- Iron syrup
- Multivitamin syrup
- R21-Matrix/M Vaccine (malaria vaccine) — full drug profile →
- Measles-Rubella vaccine — full drug profile →
Conditions studied
- Iron Deficiencies — all drugs for Iron Deficiencies →
Sponsor
Nicole Stoffel — full company profile →
Who can join
Adults 6 Months to 6 Months, any sex, with Iron Deficiencies. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Malaria and iron deficiency cause a significant burden of disease in Africa. Iron deficiency (ID) might affect immune responses to vaccination. In this double-blind randomized controlled trial, we aim to assess: (1) whether ID impairs R21/Matrix-M and measles (MR) vaccine response, (2) whether iron treatment at time of vaccination improves vaccine response.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06816524
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Iron syrup
Trials testing the same drug.
- NCT04744818 — Effects of Iron Supplementation on Pediatric Vaccine Response · NA · completed
Other recruiting trials for Iron Deficiencies
Currently open trials in the same condition.
- NCT06968936 — Long-term Outcomes Sub-Study of Preoperative Combined Iron Therapy · NA · recruiting
- NCT07315295 — Maximizing the Benefits of Iron in Ready-to-Use Therapeutic Foods for Malnourished Children in Kenya · NA · recruiting
- NCT06929806 — Multi-center Trial of Ferric Derisomaltose Versus no Intravenous Iron in Iron-deficient Subjects With Symptomatic Chroni · Phase 3 · recruiting
- NCT07236788 — Study on Supplement of Intravenous Ferric Derisomaltose to Prevent Anemia and Improve the Quality of Life in Obese Patie · NA · recruiting
- NCT06042699 — Kids With Iron Deficiency and Scoliosis · NA · recruiting
Other Nicole Stoffel trials
Trials by the same sponsor.
- NCT07315282 — The Effect of Oral Iron Supplements on Insulin and Glucose Metabolism in Overweight and Obese Women · NA · recruiting
- NCT05919472 — Effects of Oral Iron Supplementation on Vaccine Response in Iron Deficient Kenyan Women · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06816524 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Nicole Stoffel
- Last refreshed: 26 December 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06816524.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing